Promoting clearance of intracellular excessive tau is a potential therapeutic strategy for treating Alzheimer's disease. In this work, we designed and synthesized a cyclen-hybrid artificial 'hydrolase' I1-Cu(II) to cleave tau in vitro. Furthermore, a cell-permeable 'hydrolase' I2-Cu(II), derived from I1-Cu(II), was also synthesized to cleave intracellular tau proteins.
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Huang, Yadong
Mucke, Lennart
论文数: 0引用数: 0
h-index: 0
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Huang, Yadong
Mucke, Lennart
论文数: 0引用数: 0
h-index: 0
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA